Drug profile · INN
glycine
GLYCINE 1.5% IN PLASTIC CONTAINER
glycine (GLYCINE 1.5% IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Route of administration: irrigation. Current US regulatory status: approved.
Drug details — glycine
- US status
- approved
- Class
- —
- Route
- IRRIGATION
- Patents
- 8
- Programs
- 1
- Data quality
- 0.84
Quick answer
glycine (GLYCINE 1.5% IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Route of administration: irrigation. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
-
US 11813257
Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors
granted -
US 8445632
Selective poly-N-substituted glycine antibiotics
granted -
US 8324171
Ophthalmic compositions containing diglycine
granted -
US 7931919
Method of producing glycine-stabilized, lyophilized plasma
granted -
US 6677359
N-substituted glycine derivatives
expired -
US 6251903
Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist
expired -
US 6147075
Alkyl, azido, alkoxy and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist
expired -
US 6017957
Partial agonists of the strychnine insensitive glycine modulatory site of the N-methyl-D-aspartate receptor complex as neuropsychopharmacological agents
expired
Frequently asked questions
What is glycine?
glycine (GLYCINE 1.5% IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Route of administration: irrigation. Current US regulatory status: approved.
What is the brand name for glycine?
GLYCINE 1.5% IN PLASTIC CONTAINER is a marketed brand name for glycine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of glycine?
glycine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.